The latest London South East Webinar takes place on July 6. Come and hear CEO’s from Orosur Mining, Caledonia Mining, Glantus Holdings and Tekcapital speak. Please register here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,415.00
Bid: 1,413.20
Ask: 1,413.80
Change: -8.40 (-0.59%)
Spread: 0.60 (0.04%)
Open: 1,418.40
High: 1,426.40
Low: 1,406.80
Yest. Close: 1,423.40
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Sunday newspaper round-up: GlaxoSmithKline, Rare Earths, Amazon

Sun, 2nd May 2021 12:32

(Sharecast News) - Top investors in Glaxo Smith Kline are piling pressure on Dame Emma Walmsley after the activist New York hedge fund Elliott Management was revealed to have built a significant stake. Two top-20 investors in the drugs and consumer goods giant said that the chief executive's future was in doubt after four years of disappointing performance. One top-20 investor said there was "no desire to protect her" among institutional shareholders. Another said that Walmsley, 51, should step aside after her plan to break the business in two is carried out and hand over to her lieutenant, Luke Miels. - Sunday Times
Fears China will "turn off the taps" on Britain's green revolution has forced ministers to enter secret talks with seven commonwealth countries to mine their rare earths. Officials from the Department of International Trade and the Foreign Office have had meetings with representatives from Australia, Canada, Malawi and Tanzania in a bid to persuade them to supply rare earths, as well as critical metals such as lithium to the UK. Rare earths are found in abundance across the world, but are difficult to process and China controls around 90 per cent of the market. - Sunday Telegraph

Amazon is poised to seize upon the recent surge in interest in cryptocurrencies, bringing in a team of British financial regulation experts amid speculation it is on the brink of launching its own digital token. The US tech giant is understood to have poached at least six regulatory specialists from UK banking watchdog the Financial Conduct Authority (FCA) in the past two years. At least four of those have joined in the past year, taking up roles including public policy manager for regulation and chief compliance officer for payments divisions. - Sunday Telegraph

Britain will overtake Germany to become the largest economy in Europe by 2050, Transport Secretary Grant Shapps is predicting. He said Brexit has given Britain 'huge economic freedoms' to boost growth and he said he is putting aviation 'right at the heart' of the Government's mission to create Global Britain. - Financial Mail on Sunday

In another torrid year for the aviation industry, the coming month of May offers a little hope. The red-letter day in every UK airline executive's diary is 17 May, from which international leisure travel from Britain may be permitted. This week, ministers may finally divulge where and when holidaymakers can go, with a "green list" of countries that can be visited without quarantine on return. The Department for Transport insists it is on track to confirm, by "early May" as promised, whether planes can take off, and where to. - Guardian

Fund manager Ruffer has sold the majority of its holding in Bitcoin after Twitter posts by billionaire entrepreneur Elon Musk sent the price of the cryptocurrency soaring, The Mail on Sunday can reveal. Ruffer, a conservative asset management firm, surprised the City in November when it put 2.5 per cent of its customers' money - worth $600million (£433million) at the time - into Bitcoin. - Financial Mail on Sunday

Cosworth, the engineering firm best-known for producing powerful engines for high-performance Fords in the 1980s, is racing towards a float expected to value it at more than £100m. The Northamptonshire-based business has appointed Peel Hunt to advise on a stock market debut in London as soon as this summer. Cosworth, which employs almost 500 in the UK, Europe and North America, is part-owned by Kevin Kalkhoven, an Australian venture capitalist and motorsport entrepreneur, who bought the company from Ford in 2004 with his business partner Gerald Forsythe. - Sunday Telegraph

He has taken a battering for changing the name of FTSE100 funds giant Standard Life Aberdeen to Abrdn. But last night, chief executive Stephen Bird hit back, telling The Mail on Sunday that traditional fund management is 'in decline' - and revealing that the rebrand is part of a major strategy shift. The fund group, which manages £535billion, was mocked last week when it unveiled Abrdn. - Financial Mail on Sunday

Millions of employees could be given the chance to switch permanently to more flexible working arrangements under forthcoming guidance designed to encourage firms to make long-term some of the emergency changes ushered in by the pandemic. The government's flexible working taskforce is drawing up guidance - before the expected lifting of the remaining lockdown restrictions, including the requirement to work from home, on 21 June - to support the emergence of new, hybrid ways of working. For example, staff might come into offices only occasionally and work at home or at a neighbourhood cafe for the rest of the week. - Guardian

More News

GSK-Vir Covid treatment sees positive results in mild, moderate cases

GSK-Vir Covid treatment sees positive results in mild, moderate cases

Today 14:00

Monday broker round-up

(Sharecast News) - SSE: Jefferies downgrades to hold with a target price of 1,680p.

Today 13:05

FOCUS-GSK to boost spending power of pharma business post break-up

* GSK hopes June 23 investor day will mark turnaround for shares* New pharma-focused GSK will slash dividends, cut debt* Analysts encourage GSK to purchase external drug assets* Executive Luke Miels points to upcoming pipeline trial resultsBy Ludwi...

Today 12:01

UPDATE 1-CureVac may let contractors make rival vaccines if own shot fails -CEO

(Adds comments from supply chain expert)By Tilman Blasshofer and Ludwig BurgerFRANKFURT, June 17 (Reuters) - German biotech firm CureVac could allow its network of manufacturing partners to be repurposed to make vaccines developed by other companie...

17 Jun 21 20:55

CureVac may let contractors make rival vaccines if own shot fails - CEO

By Tilman Blasshofer and Ludwig BurgerFRANKFURT, June 17 (Reuters) - German biotech firm CureVac could allow its network of manufacturing partners to be repurposed to make vaccines developed by other companies should its own experimental shot fail...

17 Jun 21 17:14

IP Group investee Apollo Therapeutics completes USD145 million raise

IP Group investee Apollo Therapeutics completes USD145 million raise

17 Jun 21 09:48

BROKER RATINGS: Bank of America double upgrades Morrisons to Buy

BROKER RATINGS: Bank of America double upgrades Morrisons to Buy

17 Jun 21 09:36

Wednesday broker round-up

(Sharecast News) - Pets At Home: Berenberg reiterates buy with a target price of 540p.

16 Jun 21 12:50

UPDATE 1-Regeneron's antibody therapy cuts deaths among some hospitalised COVID-19 patients -study

* Therapy cut deaths by one-fifth in the seronegative* Can be used in combination with other treatments* Finding bodes well for other antibody treatments (Adds quote, comments on cost effectiveness)By Alistair SmoutLONDON, June 16 (Reuters) - A COVI...

16 Jun 21 12:02

Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies -study

* Antibody cocktail cut deaths by one-fifth in the seronegative* Therapy can be used in combination with other treatments* Finding bodes well for other monoclonal antibody treatmentsBy Alistair SmoutLONDON, June 16 (Reuters) - Regeneron Pharmaceuti...

16 Jun 21 06:00

Tuesday broker round-up

(Sharecast News) - Page Group: Morgan Stanley downgrades to underweight with a target price of 545p.

15 Jun 21 13:39

Consumer staples, healthcare stocks boost FTSE 100

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* FTSE 100 up 0.2%, FTSE 250 adds 0.1%June 15 (Reuters) - London's FTSE 100 index edged higher on Tuesday, lifted by gains in consumer stapl...

15 Jun 21 08:27

UPDATE 3-Astra antibody cocktail fails to prevent COVID-19 symptoms in large trial

* No reliable results from trial to show prevention of infections* AstraZeneca has five more ongoing trials* Industry testing range of antibodies (Recasts, adds details of antibody therapy, U.S. deal, analyst quote)By Vishwadha Chander and Ludwig ...

15 Jun 21 07:27

UPDATE 4-AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial

* No reliable results from trial to show prevention of infections* AstraZeneca has five more ongoing trials* Industry testing range of antibodies (Updates regulatory review of rivals)By Vishwadha Chander and Ludwig BurgerJune 15 (Reuters) - AstraZe...

15 Jun 21 07:27

Monday broker round-up

(Sharecast News) - Serco: Numis upgrades to buy with a target price of 180p.

14 Jun 21 13:49

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.